These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 2838975)
21. [The association of hepatitis-B-virus infection and hepatocellular carcinoma]. Reimer K; Meisel H Z Arztl Fortbild (Jena); 1991 Mar; 85(6):246-51. PubMed ID: 1645489 [No Abstract] [Full Text] [Related]
22. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117 [TBL] [Abstract][Full Text] [Related]
23. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690 [TBL] [Abstract][Full Text] [Related]
24. The detection of alpha-fetoprotein in HBs Ag and HBe Ag carriers. Panoyotopoulos S; Yiannacopoulos T; Margari-Papanicolaou P; Christou A Allergol Immunopathol (Madr); 1982; 10(1):1-4. PubMed ID: 6177229 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Yeh FS; Yu MC; Mo CC; Luo S; Tong MJ; Henderson BE Cancer Res; 1989 May; 49(9):2506-9. PubMed ID: 2539905 [TBL] [Abstract][Full Text] [Related]
26. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma. Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131 [TBL] [Abstract][Full Text] [Related]
27. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis]. Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859 [TBL] [Abstract][Full Text] [Related]
28. Orcein-positive hepatitis B surface antigen and liver carcinoma: their association in an Eastern US population. Keshgegian AA; Ochs RH Arch Pathol Lab Med; 1981 Apr; 105(4):190-3. PubMed ID: 6163416 [TBL] [Abstract][Full Text] [Related]
29. The relation between hepatitis B virus infection and hepatocellular carcinoma. Popper H Hepatogastroenterology; 1986 Feb; 33(1):2-5. PubMed ID: 3007316 [No Abstract] [Full Text] [Related]
31. Primary hepatocellular carcinoma and viral hepatitis B and C infection in Bangladeshi subjects. Zaman S; Khan M; Alam K; Williams R J Trop Med Hyg; 1995 Feb; 98(1):64-8. PubMed ID: 7861482 [TBL] [Abstract][Full Text] [Related]
32. Primary hepatocellular carcinoma with hepatitis B virus infection in a 16-year-old noncirrhotic patient. Gasser RW; Judmaier G; Zur Nedden D; Aufschnaiter M; Hofstaedter F Am J Gastroenterol; 1983 May; 78(5):305-8. PubMed ID: 6189392 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of hepatitis B virus and primary hepatocellular carcinoma in Asia. Obata H; Nishioka K Southeast Asian J Trop Med Public Health; 1979 Dec; 10(4):621-6. PubMed ID: 94184 [No Abstract] [Full Text] [Related]
34. [Significance of prospective follow-up cohort study in diagnosis and treatment of primary hepatic cancer among HBsAg carriers]. Lu P; Wang J; Wu Y Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):856-9. PubMed ID: 11702680 [TBL] [Abstract][Full Text] [Related]
35. Hepatitis B viral infection: part I. Clinical features. Dzik WH; Alter HJ Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684 [TBL] [Abstract][Full Text] [Related]
36. Persistent hepatitis B virus infection and hepatocellular carcinoma. Lieberman HM; Shafritz D Prog Liver Dis; 1986; 8():395-415. PubMed ID: 3012640 [No Abstract] [Full Text] [Related]
37. Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state. Feinman SV; Berris B; Cooter N; Sinclair JC; Wrobel DM Hepatogastroenterology; 1982 Apr; 29(2):58-61. PubMed ID: 7084885 [TBL] [Abstract][Full Text] [Related]
38. Link between hepatoma and hepatitis B. Br Med J; 1978 Sep; 2(6139):718-9. PubMed ID: 212155 [No Abstract] [Full Text] [Related]
39. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Sun Z; Lu P; Gail MH; Pee D; Zhang Q; Ming L; Wang J; Wu Y; Liu G; Wu Y; Zhu Y Hepatology; 1999 Aug; 30(2):379-83. PubMed ID: 10421643 [TBL] [Abstract][Full Text] [Related]
40. A case/control study of hepatitis B virus serologic markers in Senegalese patients suffering from primary hepatocellular carcinoma. Coursaget P; Maupas P; Goudeau A; Chiron JP; Raynaud B; Drucker J; Barin F; Denis F; Diop Mar I; Diop B Prog Med Virol; 1981; 27():49-59. PubMed ID: 6262871 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]